Letters Rational Testing

No evidence base for monitoring aminoglycoside levels

BMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e7264 (Published 30 October 2012) Cite this as: BMJ 2012;345:e7264
  1. James P McCormack, professor
  1. 1University of British Columbia, Vancouver, BC, Canada
  1. james.mccormack{at}ubc.ca

I was intrigued by Banerjee and colleagues’ statements that “monitoring of therapy is essential to ensure optimal treatment and prevent toxicity” and this article “reviews the available evidence for this evolving topic.”1

It is my understanding that the evidence base to support measuring aminoglycoside concentrations is weak for multiple dose …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe